KAMADA LTD
KMDA · XNASCIK 1567529fmd_1SPVJ3176CEJJECAMFY8TMQN0MManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 26 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 77 | 103 | 114 | 127 | 133 | 104 | 129 | 143 | 161 | 180 |
| Cost of revenue | 56 | 71 | 73 | 77 | 86 | 73 | 83 | 87 | 91 | 104 |
| Gross profit | 21 | 32 | 41 | 50 | 48 | 30 | 47 | 55 | 70 | 76 |
| Research and development | 16 | 12 | 10 | 13 | 14 | 11 | 13 | 14 | 15 | 13 |
| Selling, general and administrative | – | – | – | 14 | 15 | 0 | 2 | 31 | 34 | 37 |
| Operating income | (5) | 7 | 19 | 23 | 19 | (1) | 5 | 10 | 20 | 26 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Income before taxes | (5) | 7 | 20 | 23 | 19 | (2) | (2) | 8 | 13 | 23 |
| Income tax expense | 2 | 0 | (2) | 1 | 1 | 0 | 0 | 0 | (1) | 3 |
| Net income from continuing operations | (7) | 7 | 22 | 22 | 17 | (2) | (2) | 8 | 14 | 20 |
| Net income | (7) | 7 | 22 | 22 | 17 | (2) | (2) | 8 | 14 | 20 |